Alimera Sciences to Participate in the 10th Annual Craig-Hallum Alpha Select Conference in New York

NEXT STORY
RAMSAY GENERALE DE SANTE : availability of DEU on 30 June 2019
PREV STORY
Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference

VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear Cell Sarcoma of Soft Tissue

author_avatar
NASDAQ Market News

MacroGenics Provides Update on Corporate Progress and 2015 Financial Results

Eight molecules in clinical development, including six in immuno-oncology Multi-national Phase 1b/2 gastric cancer study ...

author_avatar
NASDAQ Market News